Customer Care Tel: 0161 483 5884
Email: ukcustomer@alere.com
Website: www.alere.co.uk
Connecting withBiochemistry
Triage® Cardiac Panel
Rapid, actionable information to aid in the diagnosis of acute myocardial infarction
Finally, technology that has caught up with your needs.
Rapid, quantitative measurement of CK-MB, myoglobin, and troponin I to aid in the diagnosis of acute myocardial infarction.
- Simultaneous cardiac marker results from whole blood in approximately 15 minutes
- Enables triage decisions in under two hours when used with accelerated protocol 1
- Faster diagnosis of patients with nondiagnostic ECG1,2,3
- Rapid, accurate rule out of acute myocardial infarction1,2,3
- Objective information for appropriate disposition of patients1,2,3
- Faster triage decisions to care pathways1,2,3
- Decreased length of stay in emergency department1
- Designed for compatibility with busy emergency departments and physician practices
- Simple one-step testing
- Compact and portable instrument
- Low maintenance
- Built-in quality control features
- Ng SM, Krishnaswamy P, Morissey R, Clopton P, Fitzgerald R, Maisel AS. Ninety minute accelerated critical pathway for chest pain evaluation. Am J Cardiol. 2001; 104: 1454-1456.
- McCord J, Nowak RM, McCullough PA, et al. Ninety minute exclusion of acute myocardial infarction using quantitative point of care testing of myoglobin and troponin I. Circulation.In press.
- Triage® Cardiac Panel [product insert]. San Diego, Calif; Biosite Incorporated; 2000.
“I have worked with the Triage Cardiac biomarkers point of care system since 2001. In my practice as an Emergency Physician in the UK, I have found the Triage system to be a safe, efficient and invaluable tool to manage low risk patients who present to emergency departments with undifferentiated chest pain. The ability to integrate the Triage system into an electronic patient record has enabled excellent audit and research opportunities and sets itself above most commercially available point of care systems. I have no hesitation in recommending its use.”
Dr. Beth Christian, Emergency Physician MB BS FACEM FCEM | London, UK
“In my department, we have been using Triage Cardiac marker panels along with clinical risk stratification to manage our patients with chest pain for over eight years. We are able to accurately identify patients with ACS who need urgent intervention or admission to hospital. In addition, we can identify those patients who can be safely discharged or be managed as outpatients. In that time, we have had no complaints or litigation in respect of such patients. Point of care biomarker testing has revolutionised our ability to care effectively for these patients.”
DR. L.G. Rocke, Consultant in Emergency Medicine | Royal Victoria Hospital, Belfast